News & Events

News & Events

Press Releases

May 06, 2026
Encoded Therapeutics Doses First Patient in Pivotal Study of ETX101 for Dravet Syndrome and Reports Broader Portfolio Progress
April 27, 2026
Encoded Therapeutics to Present ETX101 Data in Dravet Syndrome at the 2026 ASGCT Presidential Symposium
March 25, 2026
Encoded Therapeutics Announces FDA Alignment, Initiation of Pivotal Study, and ASGCT Presidential Symposium Presentation of ETX101 in Dravet Syndrome
View All Press Releases

Media Kit

Logo

Media Kit - Logos

Leadership Photos

Kartik Ramamoorthi, Ph.D.
Kartik Ramamoorthi, Ph.D.
Encoded Co-Founder, CEO and Board Member
Stephanie Tagliatela
Stephanie Tagliatela
Encoded Co-Founder, Chief Scientific Officer and Board Member
Salvador Rico, M.D., Ph.D.
Salvador Rico, M.D., Ph.D.
Encoded Chief Medical Officer

Photos

Encoded lab coat
Encoded lab coat
Encoded Therapeutics headquarters in South San Francisco
Encoded Therapeutics headquarters in South San Francisco
Scientists in Encoded’s sequencing lab
Scientists in Encoded’s sequencing lab
Scientist in Encoded’s lab
Scientist in Encoded’s lab
Scientist in Encoded’s lab
Scientist in Encoded’s lab
Scientist in Encoded’s lab
Scientist in Encoded’s lab
Download Photo Archive

Video Footage

Media Kit - Footage